Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

View all journals
Search
Log in

nature
search

Search

Advanced search

Filter By:

Journal Check one or more journals to show results from those journals only.

Cancer Gene Therapy (4)
Gene Therapy (4)
Nature Communications (2)
Nature (2)
British Journal of Cancer (1)

Choose more journals

Article type Check one or more article types to show results from those article types only.

Research (13)
Reviews (1)

Subject Check one or more subjects to show results from those subjects only.

Biogeochemistry
Biophysics
Cancer
Ecology
Environmental sciences
Materials science
Nanoscience and technology

Date Choose a date option to show results from those dates only.

Today
Last 7 days
Last 30 days
Last 12 months
Last 2 years
Last 5 years

Custom date range

Clear all filters

Sort by:

Relevance

Date published (new to old)

Date published (old to new)

Showing 1–14 of 14 results

Advanced filters: Author: M Havenga Clear advanced filters

Development of safe and efficient retroviral vectors for Gaucher disease

M Havenga
R Fisher
HHG van Es
Research01 Dec 1997
Gene Therapy

Volume: 4, P: 1393-1400
Neoadjuvant systemic fluorouracil and mitomycin C prior to synchronous chemoradiation is an effective strategy in locally advanced rectal cancer

I Chau
M Allen
Y Prior
ResearchOpen Access01 Apr 2003
British Journal of Cancer

Volume: 88, P: 1017-1024
“resistance is futile”

M K Brenner
Reviews06 Oct 1999
Gene Therapy

Volume: 6, P: 1646-1647
Immune control of an SIV challenge by a T-cell-based vaccine in rhesus monkeys

Vaccine elicted Gag specific cellular immune responses are shown to provide a measure of protection from disease in Mamu-A*01-negative rhesus monkeys challenged with SIV_MAC251.

Jinyan Liu
Kara L. O’Brien
Dan H. Barouch
Research09 Nov 2008
Nature

Volume: 457, P: 87-91
Revisiting the soil carbon saturation concept to inform a risk index in European agricultural soils

Storing and protecting organic carbon in agricultural soils requires knowledge on their saturation capacity. Identification of similar pedo-climatic zones allows for creating a risk index informed by the zone-specific effective saturation capacity.

T. S. Breure
D. De Rosa
E. Lugato
ResearchOpen Access18 Mar 2025
Nature Communications

Volume: 16, P: 1-12
Hexon-chimaeric adenovirus serotype 5 vectors circumvent pre-existing anti-vector immunity

Replacing parts of a viral capsid protein with those from a related virus can circumvent pre-existing antibody immunity — without compromising its intrinsic imunogenicity.

Diane M. Roberts
Anjali Nanda
Dan H. Barouch
Research16 Apr 2006
Nature

Volume: 441, P: 239-243
From Himba indigenous knowledge to engineered Fe₂O₃ UV-blocking green nanocosmetics

D. Havenga
R. Akoba
M. Maaza
ResearchOpen Access10 Feb 2022
Scientific Reports

Volume: 12, P: 1-10
Exploiting metabolic acidosis in solid cancers using a tumor-agnostic pH-activatable nanoprobe for fluorescence-guided surgery

It is well known that the pH of tumor tissue is lower than that of the corresponding normal adjacent tissue. Here, the authors report a clinical trial of a pH activatable nanoparticle for imaging tumours.

F. J. Voskuil
P. J. Steinkamp
S. A. H. J. de Visscher
ResearchOpen Access26 Jun 2020
Nature Communications

Volume: 11, P: 1-10
Fiber-chimeric adenoviruses expressing fibers from serotype 16 and 50 improve gene transfer to human pancreatic adenocarcinoma

K F D Kuhlmann
M A van Geer
J G Wesseling
Research30 Jan 2009
Cancer Gene Therapy

Volume: 16, P: 585-597
Induction of CAMEL/NY-ESO-ORF2-specific CD8+ T cells upon stimulation with dendritic cells infected with a modified Ad5 vector expressing a chimeric Ad5/35 fiber

Elisabeth H Slager
Caroline E van der Minne
Marieke Griffioen
Research16 Jan 2004
Cancer Gene Therapy

Volume: 11, P: 227-236
Selection of drug-resistant transduced cells with cytosine nucleoside analogs using the human cytidine deaminase gene

Christian M Beauséjour
Nicoletta Eliopoulos
Richard L Momparler
Research11 Oct 2001
Cancer Gene Therapy

Volume: 8, P: 669-676
Human adenovirus type 35 vector for gene therapy of brain cancer: improved transduction and bypass of pre-existing anti-vector immunity in cancer patients

E Brouwer
M J Havenga
P Sillevis Smitt
Research03 Nov 2006
Cancer Gene Therapy

Volume: 14, P: 211-219
In vivo methotrexate selection of murine hemopoietic cells transduced with a retroviral vector for Gaucher disease

M J E Havenga
D Valerio
H H G van Es
Research06 Oct 1999
Gene Therapy

Volume: 6, P: 1661-1669
Melanoma cultures show different susceptibility towards E1A-, E1B-19 kDa- and fiber-modified replication-competent adenoviruses

M Schmitz
C Graf
S Hemmi
Research16 Feb 2006
Gene Therapy

Volume: 13, P: 893-905